Home   HELP  /   AYUDA  /   求助 : help-desk@bctrials.org  /   (415) 476-5777 Click to print page  Print

Browse Trials


In response to COVID-19, some breast cancer trials have temporarily stopped enrolling new patients. Use the contact information in our trial listings to call or email the research site for information about a trial's status.

Visit COVID-19 & Cancer Clinical Trials on Metastatic Trial Talk for regularly updated information about clinical trials during the coronavirus pandemic.


Currently viewing trials
(Last updated: August 03, 2020)

Zip Code:
 

Narrow my choices:

Radius (miles): All U.S.

20 All U.S.
Early stage    Advanced 
Treatment    Non-treatment 
Phase    I     II     III 
Display Only New Trials 
 
Close
Treatment

BRCA1/2

Chemotherapy

Hormone Therapy

Radiation Oncology

Surgery

Surgery: Reconstruction

Targeted Therapy: All

Targeted Therapy: Anti-HER2 Therapy

Targeted Therapy: CDK Inhibitors

Targeted Therapy: PARP Inhibitors

Targeted Therapy: Tumor Mutations

Targeted Therapy: Other Targeted Therapy

Vaccines and Immunotherapy

Other Treatment

Non-Treatment

Activities

Complementary and Alternative Medicine

Decision Support

Diagnosing Breast Cancer

Genetics/Family History

Having Children

Lymphedema

Managing Side Effects

No Travel Required

Predicting Response to Treatment

Preventing Breast Cancer

Preventing Recurrence

Screening

Support/Education

Surveys/Interviews/Registries

Click here to view online studies and trials that do not require site visits

1

NEAREST SITE: 3 miles
UCSF Medical Center-Mount Zion
San Francisco,CA

VISITS: Number of visits unavailable

PHASE: III

NCT ID: NCT02750826

Weight Loss Program to Prevent Recurrence in Women with HER2-, Stage II-III Breast Cancer

Randomized Phase III Trial Evaluating the Role of Weight Loss in Adjuvant Treatment of Overweight and Obese Women With Early Breast Cancer (BWEL Study) Scientific Title

Purpose
To see if women who take part in a weight loss program after being diagnosed with breast cancer are less likely to have their cancer come back than those who do not take part in the weight loss program.
Who is this for?
Women with stage I or stage II HER2 negative breast cancer. You must also be overweight or obese.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups and receive the following over 2 years: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Health Education Program</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General information about healthy living and breast cancer news, over 2 years</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Health Education Program and Weight Loss Intervention</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">General information about healthy living and breast cancer news, over 2 years</li> <li class="seamTextUnorderedListItem">Telephone calls with trained coaches, about 2 calls per month for 2 years</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">If you are overweight or obese at the time of your breast cancer diagnosis, you have a greater risk of having your cancer come back (recur) than do women who are not overweight or obese.</li> <li class="seamTextUnorderedListItem">To be eligible for this study, you must be overweight or obese (BMI ò27)</li> <li class="seamTextUnorderedListItem">This study will help to see whether weight loss programs should be a part of breast cancer treatment.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02750826' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.dana-farber.org/Newsroom/News-Releases/dana-farber-study-testing-the-impact-of-weight-loss-breast-cancer-recurrence.aspx' target='_blank'>Dana Farber News Release</a> </li><li class='seamTextUnorderedListItem'><a href='http://well.blogs.nytimes.com/2016/06/27/putting-breast-cancer-on-a-diet/?rref=collection%2Fsectioncollection%2Fhealth&amp;action=click&amp;contentCollection=health&amp;region=rank&amp;module=package&amp;version=highlights&amp;contentPlacement=7&amp;pgtyp' target='_blank'>New York Times article</a> </li></ul>
See more
2

NEAREST SITE: 74 miles
UC Davis Medical Center
Sacramento,CA

VISITS: At least 3 visits

PHASE: NA

NCT ID: NCT02366806

Individualized Radiotherapy Education for Patients with Early-Stage Breast Cancer

Impact of Individualized Radiotherapy Plan Review in Patients Receiving Adjuvant Radiotherapy for Breast Cancer Scientific Title

Purpose
To compare the benefits of a standard radiation education plan to a personalized radiation education plan.
Who is this for?
Women who are scheduled to receive radiation therapy for stage I, stage II, or stage III breast cancer at the University of California, Davis.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> Participants will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Standard</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard education about treatment plan</li> <li class="seamTextUnorderedListItem">3 quality of life questionnaires during treatment</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Experimental</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">In-depth education about treatment plan</li> <li class="seamTextUnorderedListItem">3 quality of life questionnaires during treatment</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The standard of care for treating early-stage breast cancer is a lumpectomy followed by radiation. </li> <li class="seamTextUnorderedListItem">Prior to starting radiation, patients typically receive general information about radiation therapy and its potential side effects. </li> <li class="seamTextUnorderedListItem">An in-depth, personalized treatment education plan may be more beneficial.</li> </ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02366806' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.breastcancer.org/treatment/radiation' target='_blank'>BreastCancer.org: Radiation Therapy</a> </li></ul>
See more
3

NEAREST SITE: 336 miles
University of California, Los Angeles
Los Angeles,CA

VISITS: 1 visit

PHASE: NA

NCT ID: NCT02866994

An Internet-based Support Program for Women with Metastatic Breast Cancer

Project Connect: Enhancing Connections During Metastatic Breast Cancer (PCO) Scientific Title

Purpose
To study whether women with metastatic breast cancer benefit from creating a personal website about their breast cancer experience that they can share with friends, family members and other women diagnosed with breast cancer.
Who is this for?
Women with metastatic (stage IV) breast cancer who live in the greater Los Angeles area.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will participate in a 3-hour workshop to create a personal website and chronicle your breast cancer experience.</p>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02866994' target='_blank'>ClinicalTrials.gov</a> </li></ul>
See more
4

NEAREST SITE: 350 miles
Herald Cancer Association
Los Angeles,CA

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT02946697

A Social Support Program Developed for Chinese-Speaking Breast Cancer Survivors

A Culturally Sensitive Social Support Intervention Scientific Title

Purpose
To look at whether a social support program can help improve quality of life.
Who is this for?
Women who are Chinese speakers (Mandarin or Cantonese) who have been treated for DCIS or stage I, stage II, or stage III breast cancer within the last 3 years. You must also live in or near Los Angeles, California.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Culturally-Based Social Support Program</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education and peer-support program, 7 weeks</li> <li class="seamTextUnorderedListItem">Receive weekly phone calls from peer-mentor</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Wait List</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Usual care (no intervention)</li> <li class="seamTextUnorderedListItem">Option to participate in the education and peer-support program after 7 weeks</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The program will address topics including treatment-related side effects, symptoms of cancer recurrence, physical therapy and other complementary treatments, stress, depression and other emotional problems, communicating with family members, and body image. </li> <li class="seamTextUnorderedListItem">Each study participant will have the opportunity to establish a relationship with a peer-mentor who is also a Chinese-speaking breast cancer survivor.</li> </ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02946697' target='_blank'>ClinicalTrials.gov</a> </li></ul>
See more
5

NEAREST SITE: 1643 miles
University of Texas MD Anderson Cancer Center
Houston,TX

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT03429907

A Stress-Reduction Program for Women Getting Chemo Before Breast Cancer Surgery

An Early Stress-Reduction Intervention in Patients With Newly Diagnosed Breast Cancer: A Randomized Pilot Study Scientific Title

Purpose
To see whether patients who use a mind-body stress-reduction app for two weeks before starting neoadjuvant chemotherapy have lower stress, better mood, and fewer physical symptoms during treatment than patients who do not take part in this program.
Who is this for?
Women with stage I, stage II, or stage III breast cancer who will have chemotherapy before surgery (neoadjuvant treatment) at MD Anderson Cancer Center in Texas.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Mind-body exercises using an app, daily for 2 weeks before starting chemotherapy</li> <li class="seamTextUnorderedListItem">4 questionnaires, before, during and after chemotherapy</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">4 questionnaires, before, during and after chemotherapy</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The exercises are presented on an online application (<q>app</q>) on your personal electronic device.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03429907' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.breastcancer.org/tips/exercise/treatment/chemo_targeted' target='_blank'>Breastcancer.org: Exercise During and After Chemotherapy or Targeted Therapies</a> </li></ul>
See more
6

NEAREST SITE: 2064 miles
University of Toledo
Toledo,OH

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT04232319

Online Program with an Occupational Therapist for Women Who Have Been Treated for DCIS, Stage I, Stage II, or Stage III Breast Cancer and Have Sleep Problems

Feasibility of a Sleep Hygiene Education Program for Sleep Issues in Breast Cancer Survivors Scientific Title

Purpose
To evaluate whether an online program with an occupational therapist who teaches sleep hygiene can improve quality of sleep.
Who is this for?
Women who were treated for DCIS, stage I, stage II, or stage III breast cancer who are not receiving chemotherapy or radiation, are having sleep problems, and are not taking a pharmacological sleep aide.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Online session with an occupational therapist, weekly, for 30 to 45 minutes, for 3 weeks</li> <li class="seamTextUnorderedListItem">A workbook about sleep hygiene (habits) and strategies to improve quality of sleep</li> <li class="seamTextUnorderedListItem">Help from the occupational therapist about how to apply different sleep habits and strategies from the workbook</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">This study will evaluate whether an online program with an occupational therapist who teaches sleep hygiene can improve quality of sleep.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04232319' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.sleepfoundation.org/articles/sleep-hygiene' target='_blank'>SleepFoundation.org: What is Sleep Hygiene?</a> </li></ul>
See more
7

NEAREST SITE: 2139 miles
Emory University Hospital
Atlanta,GA

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT02803593

Computer and Internet-Based Support Program for Asian-American Breast Cancer Survivors

To Enhance Breast Cancer Survivorship of Asian Americans Scientific Title

Purpose
To evaluate whether an internet and computer-based information and coaching/support program designed specifically for Asian-American breast cancer survivors improves quality of life
Who is this for?
Women who have been diagnosed with breast cancer within the past 5 years and identify as Chinese, Korean, or Japanese. You must also have access to the internet through a computer, smartphone or tablet.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Support Care Needs survey at baseline</li> <li class="seamTextUnorderedListItem">Receive culturally tailored internet and computer-based information and coaching/support in one of four languages (English, Mandarin Chinese, Korean, and Japanese)</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Support Care Needs survey at baseline</li> <li class="seamTextUnorderedListItem">Standard support provided by American Cancer Society</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The program is provided in English, Mandarin Chinese, Korean, and Japanese.</li> </ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02803593' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.dukecancerinstitute.org/news/cancer-survivorship-asian-americans' target='_blank'>Duke Cancer Institute: Cancer Survivorship of Asian Americans</a> </li></ul>
See more
8

NEAREST SITE: 2163 miles
Metro Health Medical Center
Cleveland,OH

VISITS: 1-3 visit per week for 5 months

PHASE: NA

NCT ID: NCT02763228

An Exercise Study for Older African-American and White Breast Cancer Survivors

A Physical Activity Intervention to Reduce Functional Health Disparities Among Older Breast Cancer Survivors Scientific Title

Purpose
To study whether older breast cancer survivors who take part in an exercise program offered in their community have improved quality of life.
Who is this for?
Women 65 or older who have been treated for stage I, stage II, or stage III breast cancer within the last 5 years. You must also identify as non-Hispanic white or African-American.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Exercise Group</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Walking program on your own, 1-3 times per week, for 1 year</li> <li class="seamTextUnorderedListItem">Aerobic and resistance training with a trainer, 3 times per week, for 5 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">followed by</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aerobic and resistance training with a trainer, on your own schedule, for 8 months</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Support Group</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health Education and Support Group sessions, weekly, for 5 months</li> <li class="seamTextUnorderedListItem">Encouraged to participate in any Support Group sessions offered regularly, on your own schedule, for 8 months</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">You may be assigned to a group that will exercise by walking and by using resistance training, some of which will be with a personal trainer. </li> <li class="seamTextUnorderedListItem">You may be assigned to a group that will attend a Health Education and Support Group. </li> <li class="seamTextUnorderedListItem">The researchers also want to see if there are differences in how African-American and white breast cancer survivors respond to the exercise program.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02763228' target='_blank'>ClinicalTrials.gov</a> </li></ul>
See more
9

NEAREST SITE: 2246 miles
Virginia K Crosson Cancer Center
Fullerton,CA

VISITS: 1 to 4 appointments (by phone or in person) a month, for 1 year

PHASE: NA

NCT ID: NCT03154190

Supportive Care for People With Metastatic Breast Cancer

St. Judes-Stanford Comprehensive Support Initiative Scientific Title

Purpose
To learn whether supportive care from a health care coach is better than standard support for helping you make treatment decisions that include concerns about symptom management.
Who is this for?
People with newly diagnosed metastatic (stage IV) breast cancer.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Health Care Coach Support</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Sessions with a health care coach, by phone or in person, 1 at baseline and 1 after first oncology appointment</li> <li class="seamTextUnorderedListItem">Sessions with a health care coach, by phone or in person, weekly or monthly (based on need), for 1 year</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Standard of Care Support</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Standard of care support</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Health care coaches are trained to talk to and educate cancer patients and their family members about care goals and shared decision making.</li> <li class="seamTextUnorderedListItem">This trial is also enrolling people with other types of metastatic cancer.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03154190' target='_blank'>ClinicalTrials.gov</a> </li></ul>
See more
10

NEAREST SITE: 2384 miles
Duke University Medical Center
Durham,NC

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT02707471

Treatment Adherence for Stage I-III Breast Cancer Patients Taking a Hormone Therapy Drug

Improving Well-Being for Breast Cancer Patients Taking Adjuvant Endocrine Therapy Scientific Title

Purpose
To determine which type of phone counseling session helps women continue to take their anti-estrogen drugs daily.
Who is this for?
Women with stage I, stage II, and stage III hormone receptor positive (ER+ and/or PR+) breast cancer. You must also be planning on taking an anti-estrogen drug after surgery.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups and undergo the following over 1.5 years: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Intervention</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">10 phone counseling sessions with a nurse </li> <li class="seamTextUnorderedListItem">Interactive voice messaging tailored to your medication-taking behavior </li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">10 phone counseling sessions on general health education with a nurse</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">You will receive a smart medication bottle that records the time you take your drug and sends this information to the research team.</li> </ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02707471' target='_blank'>ClinicalTrials.gov</a> </li></ul>
See more
11

NEAREST SITE: 2569 miles
Icahn School of Medicine at Mount Sinai
New York,NY

VISITS: 3 visits over 1.5 months

PHASE: NA

NCT ID: NCT02657993

Hypnosis for Reducing Pain Associated With Aromatase Inhibitors

Hypnosis to Reduce Aromatase Inhibitor (AI) Associated Musculoskeletal Pain and to Improve AI Adherence: An RCT to Explore Efficacy and Cost Effects Scientific Title

Purpose
To see if hypnosis reduces aromatase inhibitor-related pain and to compare the effects (good and bad) of hypnosis to empathetic listening for pain reduction.
Who is this for?
Women with DCIS or stage I, stage II, or stage III breast cancer who are currently taking an aromatase inhibitor.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> Participants will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Hypnosis</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">3 hypnosis sessions over 1.5 months</li> <li class="seamTextUnorderedListItem">Hypnosis recording to use in between sessions, at home</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Empathetic Listening</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">3 non-hypnosis empathetic listening sessions over 1.5 months</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Aromatase inhibitors are used to treat hormone receptor positive (ER+ and/or PR+) breast cancer in postmenopausal women. </li> <li class="seamTextUnorderedListItem">Muscle pain, joint pain and decreased grip strength are some of the most common side effects of these medications.</li> <li class="seamTextUnorderedListItem">These side effects can reduce quality of life and lead women to stop taking their aromatase inhibitors. </li> <li class="seamTextUnorderedListItem">Hypnosis is a mind-body intervention that has been shown to reduce pain.</li> </ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02657993' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://clinicaltrials.gov/ct2/show/NCT02657993' target='_blank'>ClinicalTrials.gov: Trial Information</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.cancerresearchuk.org/about-cancer/cancers-in-general/treatment/complementary-alternative/therapies/hypnotherapy' target='_blank'>Hypnotherapy for Cancer Pain</a> </li><li class='seamTextUnorderedListItem'><a href='http://www.mountsinai.org/profiles/julie-b-schnur' target='_blank'>Mount Sinai: Dr. Schnur</a> </li></ul>
See more
12

NEAREST SITE: 2693 miles
Dana Farber Cancer Institute
Boston,MA

VISITS: 3 visits

PHASE: NA

NCT ID: NCT02823262

Decision Aid for Women Age 70 and Older Diagnosed with ER+, HER2- Stage I-II Breast Cancer

A Breast Cancer Treatment Decision Aid for Women Aged 70 and Older Scientific Title

Purpose
To evaluate a breast cancer treatment Decision Aid created specifically for newly diagnosed older women.
Who is this for?
Women 70 or older who have been diagnosed with estrogen receptor positive (ER+), HER2 negative breast cancer. Your tumor must be either stage I or stage II.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1: Decision Aid</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Initial surgical consultation</li> <li class="seamTextUnorderedListItem">Treatment decision assistance provided by the Decision Aid</li> <li class="seamTextUnorderedListItem">Assessments, at 1 week and 5 months after surgical consultation</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2: Control</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Initial surgical consultation</li> <li class="seamTextUnorderedListItem">Usual care assistance when making treatment decisions</li> <li class="seamTextUnorderedListItem">Assessments, at 1 week and 5 months after surgical consultation</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">There are two phases to this study. </li> <li class="seamTextUnorderedListItem">In phase I, the researchers will collect feedback about the Decision Aid from breast cancer patients age 70 and over who were treated at least six months ago and their family members and clinicians. </li> <li class="seamTextUnorderedListItem">The researchers will use this feedback to improve the Decision Aid. </li> <li class="seamTextUnorderedListItem">In Phase II, the researchers will see if the revised Decision Aid helps women age 70 and older who have been diagnosed with breast cancer make treatment decisions.</li> </ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT02823262' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://clinicaltrials.gov/ct2/show/NCT02823262?term=NCT02823262&rank=1' target='_blank'>The Decision Aid</a> </li></ul>
See more
13

No Travel Required

VISITS: Weekly phone sessions, for 6 weeks

PHASE: II

NCT ID: NCT03998618

Telephone Support to Reduce Fatigue in Women With Metastatic Breast Cancer

Telephone Support for Metastatic Breast Cancer Patients Scientific Title

Purpose
To evaluate whether a telephone-based psychotherapy program can reduce fatigue and improve activity level, mood, and cognition.
Who is this for?
Women with metastatic (stage IV) breast cancer being treated at the Indiana University (IU) Simon Cancer Center, Eskenazi Health, IU Health North, IU Health Bloomington, IU Health Ball Memorial, Franciscan Health, or St. Vincent Health.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will be randomly assigned to 1 of 2 groups: </p> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 1:</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Acceptance and Commitment Therapy: 50-minute phone sessions, weekly, for 6 weeks</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Group 2:</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Education/Support: 50-minute phone sessions, weekly, for 6 weeks</li> </ul> <p class="seamTextPara"> <i class="seamTextEmphasis">Follow-up</i> </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">30-minute phone assessments at 2 weeks, 3 months, and 6 months after study activities</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">The type of psychotherapy being studied is called Acceptance and Commitment Therapy (ACT). </li> <li class="seamTextUnorderedListItem">It teaches mindfulness exercises as well as ways to identify and engage in activities consistent with your personal values.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT03998618' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.ncbi.nlm.nih.gov/pubmed/29327085' target='_blank'>Pubmed Abstract: Acceptance and commitment therapy for symptom interference in metastatic breast cancer patients</a> </li></ul>
See more
14

No Travel Required

VISITS: Number of visits unavailable

PHASE: NA

NCT ID: NCT04160182

Online Program with an Occupational Therapist to Help Women Treated for DCIS, Stage I, Stage II, or Stage III Breast Cancer Manage Fatigue

Feasibility and Effectiveness of an Internet-based Intervention to Manage Fatigue in Breast Cancer Survivors Scientific Title

Purpose
To evaluate whether six weeks of online meetings with an occupational therapist who teaches fatigue management skills helps reduce fatigue or the effects of fatigue on quality of life.
Who is this for?
Women who were treated for DCIS, stage I, stage II, or stage III breast cancer who are currently not receiving chemotherapy or radiation, are experiencing fatigue, and are not taking medications for depression, sleep issues, or fatigue.    Full eligibility criteria
Contact research site
Close

Contact Research Sites

  • What's involved?
  • What's being studied?
  • How can I learn more?
  • <p class="seamTextPara"> You will receive the following: </p> <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Online sessions with an occupational therapist, 45 minutes each, weekly, for 6 weeks</li> <li class="seamTextUnorderedListItem">A workbook containing information, strategies, and skills to help you manage your fatigue</li> <li class="seamTextUnorderedListItem">Help from the occupational therapist in applying these skills to your life</li></ul>
  • <ul class="seamTextUnorderedList"> <li class="seamTextUnorderedListItem">Fatigue is a common side effect of breast cancer treatment.</li> <li class="seamTextUnorderedListItem">This study will evaluate whether six weeks of online meetings with an occupational therapist who teaches fatigue management skills helps reduce fatigue or the effects of fatigue on quality of life.</li></ul>
  • <ul class='seamTextUnorderedList'><li class='seamTextUnorderedListItem'>View eligibility criteria and additional trial information: <a href='https://clinicaltrials.gov/ct2/show/NCT04160182' target='_blank'>ClinicalTrials.gov</a> </li><li class='seamTextUnorderedListItem'><a href='https://www.breastcancer.org/treatment/side_effects/fatigue' target='_blank'>Breastcancer.org: Fatigue</a> </li></ul>
See more